Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Physiologic importance of protein phosphatase inhibitors.

Oliver CJ, Shenolikar S.

Front Biosci. 1998 Sep 1;3:D961-72. Review.

PMID:
9727084
2.

Protein phosphatase regulation by endogenous inhibitors.

Shenolikar S.

Semin Cancer Biol. 1995 Aug;6(4):219-27. Review.

PMID:
8541517
3.

Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.

Endo S, Zhou X, Connor J, Wang B, Shenolikar S.

Biochemistry. 1996 Apr 23;35(16):5220-8.

PMID:
8611507
4.

Phosphorylation of protein phosphatase-1 inhibitors, inhibitor-1 and DARPP-32, in renal medulla.

Higuchi E, Nishi A, Higashi H, Ito Y, Kato H.

Eur J Pharmacol. 2000 Nov 17;408(2):107-16.

PMID:
11080516
5.

Role of protein targeting to glycogen (PTG) in the regulation of protein phosphatase-1 activity.

Brady MJ, Printen JA, Mastick CC, Saltiel AR.

J Biol Chem. 1997 Aug 8;272(32):20198-204.

6.

DARPP-32 and inhibitor-1 are expressed in pancreatic beta-cells.

Lilja L, Meister B, Berggren PO, Bark C.

Biochem Biophys Res Commun. 2005 Apr 8;329(2):673-7.

PMID:
15737638
7.

Inactivation of nuclear inhibitory polypeptides of protein phosphatase-1 (NIPP-1) by protein kinase A.

Beullens M, Van Eynde A, Bollen M, Stalmans W.

J Biol Chem. 1993 Jun 25;268(18):13172-7.

8.

Protein phosphatase 1 regulation by inhibitors and targeting subunits.

Watanabe T, Huang HB, Horiuchi A, da Cruze Silva EF, Hsieh-Wilson L, Allen PB, Shenolikar S, Greengard P, Nairn AC.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3080-5.

9.

Targeting of PKA, PKC and protein phosphatases to cellular microdomains.

Sim AT, Scott JD.

Cell Calcium. 1999 Nov;26(5):209-17. Review.

PMID:
10643559
10.

Serine/threonine protein phosphatases in apoptosis.

Klumpp S, Krieglstein J.

Curr Opin Pharmacol. 2002 Aug;2(4):458-62. Review.

PMID:
12127881
11.

The inhibitor-1 C terminus facilitates hormonal regulation of cellular protein phosphatase-1: functional implications for inhibitor-1 isoforms.

Weiser DC, Sikes S, Li S, Shenolikar S.

J Biol Chem. 2004 Nov 19;279(47):48904-14. Epub 2004 Sep 2.

13.

Inhibitors of protein phosphatase-2A: topography and subcellular localization.

Tanimukai H, Grundke-Iqbal I, Iqbal K.

Brain Res Mol Brain Res. 2004 Jul 26;126(2):146-56.

PMID:
15249138
14.

Broad specificity in binding of NIPP-1, nuclear inhibitor of protein phosphatase-1, to PP1 isoforms in vivo.

Kim SE, Shima H, Nakamura K, Kikuchi K.

Tohoku J Exp Med. 2000 May;191(1):39-45.

15.

Myosin light chain phosphatase: a Cinderella of cellular signaling.

Solaro RJ.

Circ Res. 2000 Aug 4;87(3):173-5. No abstract available.

16.

Regulation of gene expression by serine/threonine protein phosphatases.

Schönthal AH.

Semin Cancer Biol. 1995 Aug;6(4):239-48. Review.

PMID:
8541519
17.
18.

Molecular determinants of nuclear protein phosphatase-1 regulation by NIPP-1.

Beullens M, Van Eynde A, Vulsteke V, Connor J, Shenolikar S, Stalmans W, Bollen M.

J Biol Chem. 1999 May 14;274(20):14053-61.

19.

Role of PP2A in intracellular signal transduction pathways.

Schönthal AH.

Front Biosci. 1998 Dec 15;3:D1262-73. Review.

PMID:
9851914
20.

[Regulatory proteins of type 1 protein phosphatase].

Kotani H, Ito M, Ichikawa K, Nakano T.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1072-82. Review. Japanese. No abstract available.

PMID:
9655965

Supplemental Content

Support Center